Testing the tonometers

Article

Intraocular pressure (IOP) measurements taken with Pascal dynamic contour tonometry (DCT) and the TonoPen appear to be influenced by central corneal thickness (CCT), according to a study published in the May issue of Acta Ophthalmologica Scandinavica.

Intraocular pressure (IOP) measurements taken with Pascal dynamic contour tonometry (DCT) and the TonoPen appear to be influenced by central corneal thickness (CCT), according to a study published in the May issue of Acta Ophthalmologica Scandinavica.

A team of researchers led by Maria Salvetat of Santa Maria della Misericordia Hospital in Udine, Italy, compared IOP measurements taken with the Pascal DCT, TonoPen and Goldman applanation tonometry (GAT).

One eye in 101 consecutive primary open-angle glaucoma patients underwent ultrasonic CCT measurement and IOP evaluation with all three systems, in random order.

After assessing the agreement between results using the Bland-Altman method, the authors concluded that the agreement with GAT measurements was higher for Pascal DCT than for TonoPen readings. Pascal DCT, however, was found to significantly overestimate IOP values compared with GAT and both Pascal DCT and the TonoPen were influenced by CCT, the influence being greater for the latter.

Recent Videos
Thomas Aaberg, MD, gives an update on Neurotech Pharmaceuticals NT-501 device for the potential treatment of retinitis pigmentosa and age-related macular degeneration, including a projected PDUFA date from the FDA at the annual ASRS meeting in Stockholm, Sweden.
Sruthi Arepalli, MD, spoke with Modern Retina about her presentation, "Assessing retinal vascular changes in alzheimer disease with radiomics: A preliminary study of fundus photography" at the annual ASRS meeting in Stockholm, Sweden.
Nathan Steinle, MD, spoke with Modern Retina about the ongoing research on the durability of sozinibercept in combination therapy with anti-VEGF-A treatments at the annual ASRS meeting in Stockholm, Sweden.
Deepak Sambhara, MD, shared an overview of his paper-on-demand, which covered real-world safety and efficacy of aflibercept, 8 mg in the treatment of neovascular age-related macular degeneration at the annual ASRS meeting in Stockholm, Sweden.
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
© 2024 MJH Life Sciences

All rights reserved.